Usefulness of a questionnaire for assessing the relationship between eating behavior and steatotic liver disease among Japanese male young adults.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
25 Jan 2024
Historique:
received: 27 06 2023
accepted: 23 01 2024
medline: 26 1 2024
pubmed: 26 1 2024
entrez: 25 1 2024
Statut: epublish

Résumé

This study aimed to reveal the relationship between eating behavior and nonalcoholic fatty liver disease (NAFLD)/metabolic dysfunction-associated steatotic liver disease (MASLD) in young adults and suggest a questionnaire for eating behavior assessment. We included 322 male graduate students at Gifu University. Diagnoses of NAFLD and MASLD were based on the presence of hepatic steatosis on ultrasonography. Eating behavior was assessed using the eating behavior questionnaire (EBQ) recommended by the Japan Society for the Study of Obesity. We assessed the eating behaviors associated with NAFLD and MASLD using logistic regression, decision tree, and random forest analyses. The median age of the participants was 22 years, and 16% and 11% had NAFLD and MASLD, respectively. The EBQ total score was significantly higher in participants with MASLD than in those without MASLD (102 vs. 90 points, P = 0.006) and in those with NAFLD than in those without NAFLD (97 vs. 90 points, P = 0.007). Among eating behavior categories, the decision tree and random forest analyses revealed that "perception of constitution and weight" was the strongest contributor for NAFLD/MASLD. Our study revealed that eating behavior assessed with the EBQ is robustly associated with NAFLD and MASLD in young male adults.

Identifiants

pubmed: 38273030
doi: 10.1038/s41598-024-52797-8
pii: 10.1038/s41598-024-52797-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2194

Subventions

Organisme : Japan Society for the Promotion of Science
ID : JP22K11774

Informations de copyright

© 2024. The Author(s).

Références

Huang, D. Q. et al. Global epidemiology of cirrhosis: Aetiology, trends and predictions. Nat. Rev. Gastroenterol. Hepatol. 20, 388–398 (2023).
doi: 10.1038/s41575-023-00759-2 pubmed: 36977794 pmcid: 10043867
GBD 2019 Hepatitis B Collaborators. Global, regional, and national burden of hepatitis B, 1990–2019: A systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol. Hepatol. 7, 796–829 (2022).
doi: 10.1016/S2468-1253(22)00124-8
Heffernan, A., Cooke, G. S., Nayagam, S., Thursz, M. & Hallett, T. B. Scaling up prevention and treatment towards the elimination of hepatitis C: A global mathematical model. Lancet 393, 1319–1329 (2019).
doi: 10.1016/S0140-6736(18)32277-3 pubmed: 30704789 pmcid: 6484702
Paik, J. M., Golabi, P., Younossi, Y., Mishra, A. & Younossi, Z. M. Changes in the global burden of chronic liver diseases from 2012 to 2017: The growing impact of NAFLD. Hepatology 72, 1605–1616 (2020).
doi: 10.1002/hep.31173 pubmed: 32043613
Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. J. Hepatol https://doi.org/10.1016/j.jhep.2023.06.003 (2023).
doi: 10.1016/j.jhep.2023.06.003 pubmed: 37984709
Rinella, M. E. et al. A multi-society Delphi consensus statement on new fatty liver disease nomenclature. Hepatology https://doi.org/10.1097/hep.0000000000000520 (2023).
doi: 10.1097/hep.0000000000000520 pubmed: 38112434
European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) & European Association for the Study of Obesity (EASO). EASL-EASD-EASO clinical practice guidelines for the management of non-alcoholic fatty liver disease. J. Hepatol. 64, 1388–1402 (2016).
doi: 10.1016/j.jhep.2015.11.004
Tokushige, K. et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. Hepatol. Res. 51, 1013–1025 (2021).
doi: 10.1111/hepr.13688 pubmed: 34533266
Tokushige, K. et al. Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020. J. Gastroenterol. 56, 951–963 (2021).
doi: 10.1007/s00535-021-01796-x pubmed: 34533632 pmcid: 8531062
Rinella, M. E. et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77, 1797–1835 (2023).
doi: 10.1097/HEP.0000000000000323 pubmed: 36727674
Glass, L., Asefa, H., Volk, M., Lok, A. S. & Tincopa, M. A. Disease knowledge, health-related quality of life, and lifestyle behavior change in patients with nonalcoholic fatty liver disease: Impact of an educational intervention. Dig. Dis. Sci. 67, 2123–2133 (2022).
doi: 10.1007/s10620-021-07052-9 pubmed: 34043121
Bellentani, S., Dalle Grave, R., Suppini, A. & Marchesini, G. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Hepatology 47, 746–754 (2008).
doi: 10.1002/hep.22009 pubmed: 18098321
Semlitsch, T., Stigler, F. L., Jeitler, K., Horvath, K. & Siebenhofer, A. Management of overweight and obesity in primary care-A systematic overview of international evidence-based guidelines. Obes. Rev. 20, 1218–1230 (2019).
doi: 10.1111/obr.12889 pubmed: 31286668 pmcid: 6852048
Ohmori, Y. et al. Association of personality (NEO-five factor inventory) with eating behaviors and physical activity levels in obese subjects in the Saku control obesity program (SCOP). Anti-aging Med. 4, 43–50 (2007).
doi: 10.3793/jaam.4.43
Kwon, Y. J. et al. The association between total protein intake and all-cause mortality in middle aged and older Korean adults with chronic kidney disease. Front. Nutr. 9, 850109 (2022).
doi: 10.3389/fnut.2022.850109 pubmed: 35445069 pmcid: 9014017
Doupe, P., Faghmous, J. & Basu, S. Machine learning for health services researchers. Value Health 22, 808–815 (2019).
doi: 10.1016/j.jval.2019.02.012 pubmed: 31277828
Samdal, G. B., Eide, G. E., Barth, T., Williams, G. & Meland, E. Effective behaviour change techniques for physical activity and healthy eating in overweight and obese adults; Systematic review and meta-regression analyses. Int. J. Behav. Nutr. Phys. Act. 14, 42 (2017).
doi: 10.1186/s12966-017-0494-y pubmed: 28351367 pmcid: 5370453
Xia, J., Yang, C., Ge, S., Feng, X. & Sun, W. Eating behavior and hypertension in Chinese. Asia Pac. J. Clin. Nutr. 30, 504–511 (2021).
pubmed: 34587710
Takezawa, J. et al. Preproghrelin gene polymorphisms in obese Japanese women. Minor homozygotes are light eaters, do not prefer protein or fat, and apparently have a poor appetite. Appetite. 63, 105–111 (2013).
doi: 10.1016/j.appet.2012.12.006 pubmed: 23257630
Tajirika, S. et al. Usefulness of health checkup for screening metabolic dysfunction-associated fatty liver disease and alcohol-related liver disease in Japanese male young adults. Sci. Rep. 13, 7987 (2023).
doi: 10.1038/s41598-023-34942-x pubmed: 37202437 pmcid: 10195773
Miwa, T. et al. Impact of body fat accumulation on metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease in Japanese male young adults. Hepatol. Res. 53, 691–700 (2023).
doi: 10.1111/hepr.13906 pubmed: 37143429
Yamamura, S. et al. MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver Int. 40, 3018–3030 (2020).
doi: 10.1111/liv.14675 pubmed: 32997882
Nguyen, V. H., Le, M. H., Cheung, R. C. & Nguyen, M. H. Differential clinical characteristics and mortality outcomes in persons with NAFLD and/or MAFLD. Clin. Gastroenterol. Hepatol. 19, 2172-2181.e2176 (2021).
doi: 10.1016/j.cgh.2021.05.029 pubmed: 34033923
Morita, A., Aiba, N., Miyachi, M. & Watanabe, S. The associations of eating behavior and dietary intake with metabolic syndrome in Japanese: Saku cohort baseline study. J. Physiol. Anthropol. 39, 40 (2020).
doi: 10.1186/s40101-020-00250-w pubmed: 33317604 pmcid: 7734750
Ishida, Y. et al. Influence of the accumulation of unhealthy eating habits on obesity in a general Japanese population: The Hisayama study. Nutrients 12, 3160 (2020).
doi: 10.3390/nu12103160 pubmed: 33081125 pmcid: 7602721
Miyoshi, R. et al. Weight control in schizophrenic patients through Sakata’s charting of daily weight pattern and its associations with temperament and character. Asian J. Psychiatr. 7, 52–57 (2014).
doi: 10.1016/j.ajp.2013.10.018 pubmed: 24524710
Cooper, A. J., Gupta, S. R., Moustafa, A. F. & Chao, A. M. Sex/gender differences in obesity prevalence, comorbidities, and treatment. Curr. Obes. Rep. 10, 458–466 (2021).
doi: 10.1007/s13679-021-00453-x pubmed: 34599745

Auteurs

Takao Miwa (T)

Health Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan. miwa.takao.a6@f.gifu-u.ac.jp.
Department of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, Gifu, Japan. miwa.takao.a6@f.gifu-u.ac.jp.
Gifu University Hospital, Gifu, Japan. miwa.takao.a6@f.gifu-u.ac.jp.

Satoko Tajirika (S)

Health Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
Department of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, Gifu, Japan.
Gifu University Hospital, Gifu, Japan.

Tatsunori Hanai (T)

Department of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, Gifu, Japan.
Gifu University Hospital, Gifu, Japan.

Nanako Imamura (N)

Health Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.

Miho Adachi (M)

Health Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
Gifu University Hospital, Gifu, Japan.

Ryo Horita (R)

Health Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
Gifu University Hospital, Gifu, Japan.

Taku Fukao (T)

Health Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
Gifu University Hospital, Gifu, Japan.

Masahito Shimizu (M)

Department of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, Gifu, Japan.
Gifu University Hospital, Gifu, Japan.

Mayumi Yamamoto (M)

Health Administration Center, Gifu University, 1-1 Yanagido, Gifu, 501-1193, Japan.
Gifu University Hospital, Gifu, Japan.
United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, Gifu, Japan.

Classifications MeSH